Presumed consent and priority allocation systems for organ donation legislation in the United States: Making the moral case by Shapiro, Anna K. & DePergola, Peter A., II
Online Journal of Health Ethics 
Volume 16 Issue 2 Article 4 
2020 
Presumed consent and priority allocation systems for organ 
donation legislation in the United States: Making the moral case 
Anna K. Shapiro 
College of Our Lady of the Elms 
Peter A. DePergola II 
University of Massachusetts Medical School; College of Our Lady of the Elms, 
drpeterdepergola@gmail.com 
Follow this and additional works at: https://aquila.usm.edu/ojhe 
 Part of the Bioethics and Medical Ethics Commons 
Recommended Citation 
Shapiro, A. K., & DePergola, P. A. (2020). Presumed consent and priority allocation systems for 
organ donation legislation in the United States: Making the moral case. Online Journal of Health 
Ethics, 16(2). http://dx.doi.org/10.18785/ojhe.1602.04 
This Article is brought to you for free and open access by The Aquila Digital Community. It has been accepted for 
inclusion in Online Journal of Health Ethics by an authorized editor of The Aquila Digital Community. For more 
information, please contact Joshua.Cromwell@usm.edu. 
Presumed Consent and Priority Allocation Systems for Organ Donation Legislation 
https://doi.org/ 10.18785/ojhe.1602.04 
 
ere human life was cheap and test subjects plentiful were used as 
laboratories. 
In 2010 the US government apologized to Guatemala for allowing U.S. doctors to infect 
Guatemalan prisoners and mental patients with syphilis 65 years earlier, while ac-
knowledging dozens of similar experiments were performed in the United States. 
Among these included studies that often involved making healthy people sick or keeping 
sick patients ill, such as in the Tuskegee syphilis study. 
These experiments were often life threatening and took place with the direct approval 
and/or supervision of some of the country’s most prestigious research institutions and 
some of the country’s leading medical researchers. Among these was the prestigious cancer 
research center in New York City, Sloan Kettering Hospital and its director of cancer re-
search Chester Southam, MD. 
Human subjects 
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In recent decades, developed nations, such as the United States, have seen the gap be-
tween the demand and th  supply of transplantable orga s widen, despite national 
campaigns intended to promote donor registration. This organ shortage crisis has de-
prived thousands of a basic quality of life and has caused a substantial increase in the 
cost of alternativ  medical care such as dialysis. In an attempt to address the shortage, 
som  countries have instituted explicit “opt-out” and “priori y allocation” policies that 
operate under the principl  of presumed c ns nt and offer higher priority on trans lan-
tation lis  to registered donor . This paper eeks to justify such legislation, exploring 
the ethical implications and highlighting the potential benefits of an opt-out and priori-
ty allocation organ donation system. I  argues that such policies should be made  legis-









Over the course of the last century, the advancement 
of transplantation techniques combined with factors includ-
ing increased incidence of metabolic disease and population 
aging have caused an increased demand for viable organs 
and tissues (Wynn, 2011). Unfortunately, the demand for 
such biological materials significantly surpasses the number 
available for donation. In January 2019, the U.S. Department 
of Health and Human Services reported that over 113,000 
Americans were registered on the national transplant wait-
ing list and roughly 20 registered patients die each day wait-
ing for a donation (U.S. Department of Health and Human 
Services, 2019). Despite increased public awareness cam-
paigns and other attempts to promote donor registration, the 
gap between supply and demand continues to widen as the 
number of patients on waiting lists has continued to climb 
over last decade (Abadie & Gay, 2006). The pressing short-
age has created a forum for debate amongst U.S. legislators 
on the policies of two diametrically opposed systems: the 
opt-in (explicit consent) and the opt-out (presumed consent) 
systems of organ donation registration. Opt-in organ dona-
tion systems require an individual to explicitly express their 
consent to become a potential donor, usually by means of a 
state registry, whereas opt-out systems  presume consent un-
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Over the course of the last century, the advance-
ment of transplantation techniques combined with factors 
including increased incidence of metabolic disease and 
population aging have caused an increased demand for vi-
able organs and tissues (Wynn, 2011). Unfortunately, the 
demand for such biological materials significantly surpass-
es the number available for donation. In January 2019, the 
U.S. Department of Health and Human Services reported 
that over 113,000 Americans were registered on the nation-
al transplant waiting list and roughly 20 registered patients 
die each day waiting for a donation (U.S. Department of 
Health and Human Services, 2019). Despite increased pub-
lic awareness campaigns and other attempts to promote 
donor registration, the gap between supply and demand 
continues to widen as the number of patients on waiting 
lists has continued to climb over last decade (Abadie & 
Gay, 2006). The pressing shortage has created a forum for 
debate amongst U.S. legislators on the policies of two dia-
metrically opposed systems: the opt-in (explicit consent) 
and the opt-out (presumed consent) systems of organ do-
nation registration. The current protocol for organ pro-
curement and allocation in the U.S. operates under the 
guidelines set out by an opt-in system. The inability of the 
whereas opt-out systems  presume consent unless an indi-
vidual expresses their refusal to donate (Glazier, 2011). 
 
current system to effectively address this ongoing organ 
deficiency underscores the need for change at the state and 
federal level. 
 In response, this paper argues for a departure from 
the current opt-in system and the theoretical, subsequent  
adoption of opt-out and priority allocation system. 
 
 Organ Shortage as a Public Health Issue 
 
 Transplantation as a Solution to Organ Failure 
 
             While the need for transplantable organs can be 
traced back to antiquity, it was not until the twentieth cen-
tury that advancements in modern medicine have been 
able overcome the technical limitations that previously 
prevented it from becoming the routine practice it is today 
(Starzl, 1994). Early twentieth century attempts at renal 
xenotransplantation between human recipients and mam-
malian donors (i.e., sheep, pigs, goats, and of transplanted 
organs. It was not until 1944 when Peter Medawar demon-
strated that rejection of transplanted organs is an immuno-
logic process in itself.    die each day waiting for a donation 
(U.S. Department of Health and Human Services, 2019). 
Despite increased public awareness campaigns and other 
attempts to promote donor registration, the gap between 
supply and demand continues to widen as the number of 
patients on waiting lists has continued to climb over last 
decade (Abadie & Gay, 2006). The pressing shortage has 
created a forum for debate amongst U.S. legislators on the 
ARTICLE INFORMATION                       ABSTRACT 
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            Medawar’s work focused on the rejection of 
skin grafts, using rabbits and cattle to investigate the 
process. His research identified immune responses via 
lymphocyte infiltration of genetically different grafts 
as being responsible for organ rejection and found that 
an exchange of skin grafts between monozygotic, as 
well as dizygotic, pairs retained their test twin grafts 
with little to no indications of rejection, while still 
demonstrating rejection of grafts from unrelated third 
party donors (Anderson et. al, 1951). In a bold applica-
tion of Medawar’s work, a team led by physicians Jo-
seph Murray, John Harrison, and John Merrill per-
formed the first long-term successful kidney trans-
plant between identical twins in 1954 (Merril et. al, 
1956). Their landmark success paved the way for the 
development of increasingly better methods of histo- 
compatibility matching, organ procurement and 
preservation, and numerous innovations in surgical 
techniques. Such efforts ultimately made it possible to 
successfully engraft all of the major organs and bone 
marrow cells in humans. 
Organ Shortage as a Public Health Issue 
            Since 1995, over 161,000 patients registered on 
waiting list have died before an organ became availa-
ble in the U.S. (OPTN, 2019). More recent statistics 
from the  U.S. Department of Health and Human Ser-
vices reported that as of January 2019, over 113,000 
Americans were registered on the national transplant 
waiting list and roughly 20 of those patients die each 
day waiting for a donation (U.S. Department of Health 
and Human Services, 2019). The increasing demand 
for transplantable organs compounded with the na-
tionwide deficit of registered donor has deprived 
thousands of American patients of a new and better 
quality of life. Despite campaign efforts and other at-
tempts to promote donor registration, the gap between 
supply and demand continues to widen. 





 Organ scarcity is not unique to the United 
States; it is a pervasive challenge that all medically ad-
vanced countries face. In recent decades, global politi-
cal strategies have taken steps to address the shortage 
by changing two components of transplantation legis-
lation: presumed consent and allocation priority. The 
implementation of these two systems operate effec-
tively by changing the status quo of organ donation 
and giving registered donors priority among the pool 
of individuals in need of organ transplantation. The 
joint implementation of these two systems has yielded 
beneficial effects in countries such as Israel and Singa-
pore. Proving national and international efforts are ef-
fective in facilitating change when they are supported 
by regional and global action within agreed policy 
frames. 
Explicit opt-out laws have long been among the 
major interventions used to increase the pool of poten-
tial donors in countries such as Austria, Belgium, the  
 
 
Czech Republic, Finland, France, Greece, Hungary, Is-
rael, Italy, Luxembourg, Norway, Poland, Slovenia, 
Spain, Sweden and Turkey. There is evidence that 
supports the association between presumed consent 
and increased donation rates and that countries with 
opt-out laws have rates 25 to 50% higher than those in 
countries requiring explicit consent (Abadie & Gay, 
2006). One study found that the rates of deceased do-
nor rates (per-million population) were 42.7% higher 
in opt-out countries. However, the study revealed a 
paradox in which the opt-in countries reported 70.5% 
higher rates of living donors compared to opt-out 
countries (Abadie & Gay, 2006). Hence, presumed 
consent appears to be only one of several influential 
factors. Other factors include potential donor availabil-
ity, transplantation infrastructure, health care spend-
ing and public attitude towards donation (Rithalia et. 
al, 2009), as well as an agreement of the next-of-kin 
and donor registry infrastructure (Bilgel, 2012). 
In 1987, Singapore introduced the Human Or-
gan Transplant Act, which instituted an opt-out sys-
tem that presumed consent to removal of organs for 
transplantation upon death and apply priority 
allocation. Under priority allocation systems, those 
who object and withdraw their consent to donate up-
on their death also forfeit a priority stop on the na-
tional transplantation waiting list, should they require 
a transplantation in future. The combined system not 
only changed the status quo of donation but provided 
an incentive for donation: receiving priority on the 
waiting list (Breyer & Kliemt, 2007). A concern with 
combining the opt-out and priority allocation system 
is that the priority rule cannot prevent the free-rider 
problem if the introduction of an opt-out system has 
already generated a sufficient organ supply. Overall, 
Singapore’s combination of presumed consent and 
priority status has been successful in increasing organ 
donations. 
Following suit, the Organ Transplant Act came 
into effect in Israel in 2010. The new law introduced a 
priority point system to motivate individuals to do-
nate their organs by granting prioritization in organ 
allocation to candidates who have either been regis-
tered as organ donors for at least three years prior to 
transplantation request, or have given explicit consent 
for organ donation of their deceased next-of-kin 
(Lavee et. al, 2010). Israel’s system also rewards those 
who are willing to act as living donors for kidney or 
liver donation with a preferential status as a recipient. 
A person can also gain priority points by signing a 
donor card, making a non-directed/non-specified or-
gan donation during their lifetime, or being a first-
degree relative signing a donor card or consenting to 
procurement of organs after death. The resulting 
tiered system includes maximum priority, regular pri-
ority and second priority. Maximum priority is grant-
ed to candidates if: (i) consent has been given for or-
gan donation from a deceased first-degree relative or 
(ii) they donated a kidney, a lobe of their liver or a 
lobe of their lungs in the course of their life to a non-
specified recipient. Regular priority is given to candi-
dates who hold a donor card, that is, those who have 
consented to donate their organs after their death. Sec-
ond priority is granted to candidates with a first-
degree relative who holds a donor card, even if they 
do not hold a donor card themselves. As a result, the 
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and, ultimately, a significant increase in the numbers 
of transplants (Cronin, 2014) 
 
The Spanish Model 
 
In 2016, Spain boasted an impressive number of 
deceased donors at 43.4 per million population (pmp), 
an increase from 39.7 pmp in 2015 and 36 pmp in 2014. 
The 2016 Spanish rates are much higher than the EU 
average (19.6 pmp) and the U.S. average (26.6 pmp). 
Having the world’s highest rates of donation per capi-
ta, Spain has become the world leader in organ trans-
plants. In 1979, Spain instituted its opt-out system 
through the implementation of presumed-consent leg-
islation and since then, has required all prospective 
donors to be declared dead on neurological criteria by 
a minimum of three physicians (Gundle, 2005). Once 
death has been declared, any individual who has not 
formally registered an opposition is considered a po-
tential donor and the process of organ procurement 
begins. This system, combined with an ingrained soci-
etal respect for organ donors, has contributed to 
Spain's successful organ procurement program. 
The Spanish model for opt-out donor registra-
tion offers simple and practical principles to guide the 
development and implementation of policies at both 
the national and state levels. Taken together, these 
principles reflect the multifaceted determinants of or-
gan transplantation and the coordinated multi-sectoral 
action required to implement effective legislation. 
 
The Case Against Opt-Out Organ Donation 
Legislation 
Libertarianism and Organ Donation: Loss of Autonomy 
 
The primary points of contention within the de-
fault debate are between opt-in and opt-out statutes, 
founded in the interpretation and adherence to the au-
tonomy of the donor under the assertions of the Liber-
tarian model. Those in objection to the presumed con-
sent model assert that such systems place limitations 
on and unjustly reduce patient autonomy. According 
to this view, it is wrong to invade and assume posses-
sion of someone’s body without that person’s consent 
(Gill, 2004), and that the government is already too in-
volved in the lives of its citizens. Such claims are 
founded upon the principles set out under libertarian-
ism, a political ideology that places emphasis on safe-
guarding individual liberties and minimizing gov-
ernment involvement in the affairs of its citizens. One 
of the fundamental assumptions of libertarianism is 
the right to self- ownership; libertarianism asserts the 
full right to control the use of one’s own person and 
the need for explicit consent without external influ-
ence or coercion (Vallentyne, 2008). Proponents of this 
ideology would argue that presumed consent laws 
further invade the affairs of the governed by assuming 
possession over their body, and thus violating their 
right to self-ownership. 
 
An Imperfect Solution 
 
While it is evident that opt-out systems are suc-
cessful in increasing rates of registered organ donors, 
it is important to note that it is not failsafe solution. 
Even in opt-out countries such as Spain and France, a 
near 100% registration rate does not translate into sur-
plus of organs, a fact often overlooked when advocat-
ing for opt-out systems. Even in countries with pre-
sumed consent, there is still a waiting list for organs. 
This can be attributed to the fact that majority of regis-
tered donors do not die in ways or conditions suitable 
for organ donation. In fact, only approximately 3 out 
of every 1000 deaths occur in a way that allows for or-
gan donation (U.S. Department of Health and Human 
Services, 2019). While the institution of opt-out sys-
tems increases the rates of registered donors, the death 
of an organ donor does not guarantee an organ dona-
tion. 
 
The Case in Favor of Opt-Out Organ Donation 
Legislation 
Utilitarianism and Organ Donation: Increase Autonomy 
 
On the other side of the argument are those 
who believe the United States should adopt a system 
of presumed consent for organ procurement. They re-
spond to the argument over a loss of autonomy by 
countering that a presumed consent model actually 
provides more autonomy than expressed consent be-
cause it allows the donor, not his or her family mem-
bers, to make the final decision. They maintain that 
asking a family for a loved one's organs at a time of in-
tense grief is cruel and unnecessary and that, by pre-
suming consent, the family's conflict over this decision 
is avoided. Furthermore, there are those who argue 
that the burden of communicating and registering 
preference should fall on those who object to donating, 
not those who support it, because the goal of 
transplantation is one that must be widely accepted by 
the public. Communicating objection rather than ac-
ceptance would also increase accuracy, asserting that 
objectors are more likely to register their opposition 
than supporters are to sign up as donors. Anecdotally 
speaking, people are more inclined to write bad re-
views than they are good ones; more inclined to ex-
press opposition than approval. Following this argu-
ment, there would be fewer mistakes in interpreting a 
potential donor's wishes. To conclude this line of rea-
soning, Gill (2004) suggests that all mistakes in inter-
preting a donor's preferences have the same moral 
worth; it is no worse, Gill says, to assume that some-
one wants to donate, take his or her organs, and then 
find out that he or she objected than to wrongly as-
sume that someone did not wish to donate and there-
fore forgo potential organs.  
Moreover, survey data indicates a significant 
disagreement between preferences for donation and 
donor card registrations. In particular, results from a 
well-known survey (Gallup, 1993) indicate that 
while most Americans favor organ donation (89%) 
and would like to donate their organs after death 
(69%), only a few grant permissions for postmortem 
organ procurement on their driver’s license or organ 
donor  card  (28%). 
Ultimately, supporters of presumed consent 
law also employ a utilitarian argument as support for 
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implementing such a policy that claims that presumed 
consent provides the greatest good for the greatest 
number of people by harming no one and benefiting 
many. This paper argues that there is a proportionate 
moral case in favor for the implementation of pre-
sumed consent legislation within the United States. 
From a utilitarian perspective, it represents the routine 
disposal of a highly valuable commodity, one which 
has the potential to save lives. 
 
Potential Economic Impact of Organ Donation 
 
The economic toll of organ impairment and 
dysfunction place an immense strain on healthcare in-
frastructures. In 2014, more was spent by Medicare on 
chronic renal disease treatment, such as dialysis, than 
all cancer treatments combined, despite cancer claim-
ing nearly 12 times as many lives as chronic renal dis-
ease. (Liyanage et al, 2015). On a national level, the 
United States Ultimately, the burden of cost of end-
stage organ disease is a global economic crisis, with 
over $1 trillion spent over a decade on chronic renal 
disease alone (Liyanage et al, 2015).  
 In recent years, the question of how many 
defaults influence economic choice has become an is-
sue of great interest amongst legislators, in part be-
cause it is believed that organic default systems can 
reduce the burden place by chronic disease on both 
the individual and healthcare infrastructures. As a 
model, the presumed-consent policy in Spain is cost-
effective, saving the National Health Service more 
than 200,000 Euros in medical costs for each kidney 
transplant preformed on a patient on dialysis (Lopez-
Navidad & Caballero, 2001). 
 
Corrective Vision: A Model for Legislation  
Consideration 
 
            This section briefly sketches a plausible model 
for organ donation in the U.S. Although simple, the 
model takes into consideration three components of 
transplantation legislation implemented globally and 
their effect in addressing the organ shortage crisis: (1) 
the implementation of presumed consent policies; (2) 
the implementation of allocation priority systems for 
registered organ donors (3) educational programs for 
hospitals, ICU staff, coordinators, and the general pub-
lic. 
Implementing Presumed Consent Policies 
 
According to the concept of presumed consent, 
anyone can be an organ donor after his or her death 
unless the individual had documented objection dur-
ing his or her lifetime and permission of family mem-
bers is not required. In countries that have accepted 
the concept of presumed consent, such as Spain, there 
is the highest number of organs from deceased donors. 
Reciprocal Allocation of Organs 
 
Universal donor systems place no special con-
ditions on the relationship between donor status and 
transplant allocation, whereas contingent entitlement 
systems mandate reciprocity by giving consenting pot- 
Educational Programs 
 
One of the greatest barriers to increasing the 
rates of organ donation is the lack of education and 
misconceptions of organ donation by the public. With-
in the past decade, Donor Action Programs have been 
carried out across Europe in the form of public educa-
tion programs via broadcast and print media, schools, 
universities, and public awareness campaigns. This, in 
conjunction with training programs for hospitals and 
ICU staff, have resulted in a 53% increase in organ do-
nation (Tuppin & Savoye, 2006). 
In the U.S., with support from the Department 
of Health and Human Services and the Health Re-
sources and Services Administration, the Program of 
Organ Donation Break- Through involving collabora-
tion between the transplant community and the gen-
eral public was established in 2003 (Abouna, 2008) As 
a result, the number of organs from deceased donors 
increased by 8% per year (Punch et. al, 2007). It has al-
so been recommended by the United Network for Or-
gan Sharing that general physicians should educate 
their patients about organ donation (United Network 
for Organ Sharing, 2007). Raising awareness has 
shown to increase the rates of organ donor registration 
by creating a better public understanding of the pro-





             The current protocol for organ procurement 
and allocation in the U.S. operates under the guide-
lines set out by an opt-in system. The inability of the 
current system to effectively address this ongoing or-
gan deficiency underscores the moral need for change 
at the state and federal level. In response, this paper 
has argued for a departure from the current opt-in sys-
tem and the ethical justification of a theoretical, subse-
quent adoption of opt-out and priority allocation sys-
tem. 
 While it seems unlikely that the United States 
will make the transition to a system of presumed con-
sent for organ procurement in the near future, the eth-
ical impetus of transitioning to an opt-out system re-
mains a priority in American medicine today, along 
with the autonomous right of the competent patient to 
make all of his or her own medical decisions. Based on 
the proportion of people who report being willing to 
donate their organs and those who actually register to 
do so, the organ shortage problem stems in large part 
from a moral failure to obtain permission to recover 
organs. This critical problem requires education, ac-
tion, and a national conversation about human agency 
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